Undeterred Capital
Actively deployingLos Angeles · Pre-Seed–Seed · 4 people tracked
Investment thesis
The firm believes that significant opportunities exist in applied robotics and biological platforms where operational and commercial challenges, rather than technical limitations, are the primary barriers to success. In robotics, the firm sees value across the entire stack where many industries have yet to achieve sustained deployment. In biological sciences, the firm expects scientific breakthroughs in synthetic biology, materials science, and drug discovery to create transformative value in the coming decades.
Source: firm website, verified Jul 20, 2026.
Team · 4 people
from the firm's websiteFounder of Undeterred Capital in 2020, Joe is an entrepreneur who previously co-founded and served as COO of Multiply Labs, a pharma robotics company spun out of MIT specializing in cell and gene therapy manufacturing. He also served as a venture partner at MarsBio and co-founded the C19 Coalition, a non-profit focused on COVID-19 response. He regularly lectures on deep tech commercialization at universities including MIT, Caltech, and UCLA.
Emily serves as both an Associate and Head of Research at Undeterred Capital, focusing on emerging trends in deep tech and biotech through industry analysis. She supports the investment team in diligence and portfolio company assistance. She holds a PhD in Biomechanics from UC Berkeley with specializations in cell biology and material science, and was previously a Fellow at MPM Bioimpact in Boston.
Kylie is an Investment and Research Analyst at Undeterred Capital interested in technological innovation and supporting companies from ideation to launch. She brings startup experience to her diligence and support work. She holds a PhD in Chemical Engineering from USC where she conducted interdisciplinary biophysics research and completed the Nucleate LA Activator program as a finalist in 2023.
Paul serves as CFO at Undeterred Capital in a part-time capacity, overseeing operations, legal, audit, tax, annual reporting, and compliance. He brings over 20 years of CFO experience in biotech venture firms, including a role since 2006 at BioStar Ventures (a $200M firm) and prior tenure at Windward Ventures. He also served as CEO and Chairman at VSI Enterprises and holds an MBA from Loyola University of Chicago.
What they invest in
from 2 of 21 portfolio companiesAdvanced Manufacturing ×1AI & Machine Learning ×1Biotech ×1Deep Tech ×1Developer Tools ×1Hardware ×1Healthtech ×1SaaS ×1
HQs:United States×2
Investments · 21 tracked
founders shown can be your intro pathEarly stage ovarian cancer diagnostics.
Private, reusable, verifiable, digital credentials.
Harnessing RF engineering for deep space.
Cascade Space develops software tools and infrastructure for designing, building, testing, and operating spacecraft communication systems. The company serves aerospace and space companies seeking to accelerate development with reduced team requirements.
Advanced ManufacturingDeveloper ToolsHardwareSaaSSpace TechSan Francisco, US
Miniaturizing the chemical plant via robotics & chemistry language processing.
Scalable gas fermentation for carbon negative food production.
Creating a sustainable healthcare plan that makes it easy to actually achieve better health.
Epigenomic tools for clinicians and researchers.
Pre-treatment process for extracting and refining critical battery elements.
Leading the future of healthcare with personalized at-home testing solutions.
Using synthetic biology to manage risk within the food supply chain.
Chemistry simulations for drug formulation.
Machine vision for analysis of semiconductor quality.
First-in-class molecular diagnostic platform to enable scalable, point-of-care disease diagnosis.
Decarbonizing the shipping industry through hydrogen integration.
Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery. The company aims to accelerate pharmaceutical development and reduce clinical trial failure rates through human-first biological prediction models.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Robert DiFazio(Founder)inJuliana Hilliard(Founder)inRobertJuliana
Making industrial automation as easy as ERP implementation.
Reinventing fish processing for a larger, more sustainable bottom-line.
Virtual tissues to design real drugs.
Automating pest and disease control with light - healthier plants with less chemicals.
Community-led development of promising treatments to rare diseases.
Frequently asked questions
- What stage does Undeterred Capital invest at?
- Undeterred Capital invests at the Pre-Seed, Seed stages.
- What is Undeterred Capital's typical check size?
- Undeterred Capital typically writes checks of $500K – $1M.
- What sectors does Undeterred Capital focus on?
- Undeterred Capital focuses on AI & Machine Learning, Biotech, Deep Tech, Robotics.
- Where is Undeterred Capital located?
- Undeterred Capital is headquartered in Los Angeles, US.
- Does Undeterred Capital lead rounds?
- Yes, Undeterred Capital leads investment rounds.
Similar investors
Data Collective identifies and supports ambitious company founders developing technology-driven solutions. The firm focuses on companies using innovation to restore predictability in an unstable world, with demonstrated expertise across clean energy, gene therapy, sustainable agriculture, and machine learning applications in healthcare.
Hyderabad Angels is one of India's leading angel networks, comprising experienced entrepreneurs, industrialists, and family offices. The network provides capital, mentorship, and networks to early-stage startups, leveraging the lived experience and relationships of its members across multiple industries and economic cycles.
Creative Ventures is a deep tech venture capital firm founded in 2016 that invests in early-stage companies developing breakthrough technologies to address critical global challenges in climate, industry, health, and computing.
Starship VC backs contrarian engineers and repeat founders developing deep technology solutions across hardware, robotics, energy, space, advanced manufacturing, AI infrastructure, and biotech platforms. The firm focuses on fundamental advances that compound over decades and expand human agency.
Yu Galaxy is a Silicon Valley-based venture capital firm founded in 2020 by P.R. Yu. Operating as a solo GP-led firm, it invests in visionary founders across AI, healthcare, defense, and automation with a focus on delivering measurable impact and outsized returns.